Archean Chemical Industries Limited (NSE:ACI)
552.00
-0.70 (-0.13%)
Mar 12, 2025, 3:29 PM IST
NSE:ACI Income Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2018 |
---|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 - 2018 |
Revenue | 9,793 | 13,301 | 14,411 | 11,304 | 7,408 | 6,082 | Upgrade
|
Revenue Growth (YoY) | -31.45% | -7.70% | 27.48% | 52.60% | 21.80% | 7.54% | Upgrade
|
Cost of Revenue | -33.5 | 1,124 | 192.41 | 537.06 | 212.55 | 156.44 | Upgrade
|
Gross Profit | 9,827 | 12,177 | 14,218 | 10,767 | 7,195 | 5,925 | Upgrade
|
Selling, General & Admin | 673.05 | 836 | 795.61 | 462.37 | 440.49 | 446.88 | Upgrade
|
Other Operating Expenses | 6,009 | 6,699 | 7,083 | 5,596 | 4,128 | 3,756 | Upgrade
|
Operating Expenses | 7,441 | 8,239 | 8,565 | 6,727 | 5,122 | 4,721 | Upgrade
|
Operating Income | 2,386 | 3,938 | 5,654 | 4,040 | 2,073 | 1,205 | Upgrade
|
Interest Expense | -79.77 | -69.21 | -940.09 | -1,609 | -1,303 | -1,215 | Upgrade
|
Interest & Investment Income | 21.21 | 21.21 | 41.36 | 13.62 | 8.57 | 0.19 | Upgrade
|
Currency Exchange Gain (Loss) | 79.05 | 79.05 | 127.76 | 23.9 | 92.85 | -161.92 | Upgrade
|
Other Non Operating Income (Expenses) | 22.68 | 41.51 | 38.84 | 28.76 | 21.29 | -2.26 | Upgrade
|
EBT Excluding Unusual Items | 2,429 | 4,011 | 4,922 | 2,497 | 893.22 | -174.27 | Upgrade
|
Gain (Loss) on Sale of Investments | 231.02 | 231.02 | 37.8 | 12.59 | 13.98 | 10.81 | Upgrade
|
Gain (Loss) on Sale of Assets | -0.36 | -0.36 | 0.55 | 0.21 | - | 1.46 | Upgrade
|
Asset Writedown | - | - | - | - | -2.55 | -4.9 | Upgrade
|
Other Unusual Items | -401.83 | - | - | - | - | - | Upgrade
|
Pretax Income | 2,288 | 4,272 | 5,117 | 2,510 | 904.65 | -166.9 | Upgrade
|
Income Tax Expense | 628.28 | 1,082 | 1,291 | 628.04 | 238.59 | 195.29 | Upgrade
|
Earnings From Continuing Operations | 1,660 | 3,190 | 3,826 | 1,882 | 666.06 | -362.19 | Upgrade
|
Minority Interest in Earnings | 2.17 | 0.07 | - | - | - | - | Upgrade
|
Net Income | 1,662 | 3,190 | 3,826 | 1,882 | 666.06 | -362.19 | Upgrade
|
Net Income to Common | 1,662 | 3,190 | 3,826 | 1,882 | 666.06 | -362.19 | Upgrade
|
Net Income Growth | -58.23% | -16.62% | 103.26% | 182.57% | - | - | Upgrade
|
Shares Outstanding (Basic) | 124 | 123 | 110 | 103 | 103 | 103 | Upgrade
|
Shares Outstanding (Diluted) | 124 | 123 | 111 | 103 | 103 | 103 | Upgrade
|
Shares Change (YoY) | 0.23% | 11.47% | 7.10% | - | - | 40.42% | Upgrade
|
EPS (Basic) | 13.46 | 25.90 | 34.66 | 18.22 | 6.45 | -3.51 | Upgrade
|
EPS (Diluted) | 13.45 | 25.87 | 34.59 | 18.22 | 6.45 | -3.51 | Upgrade
|
EPS Growth | -58.33% | -25.21% | 89.85% | 182.51% | - | - | Upgrade
|
Free Cash Flow | - | 1,715 | 3,962 | 2,179 | 1,086 | -44.8 | Upgrade
|
Free Cash Flow Per Share | - | 13.91 | 35.82 | 21.10 | 10.51 | -0.43 | Upgrade
|
Dividend Per Share | 1.000 | 3.000 | 2.500 | - | - | - | Upgrade
|
Dividend Growth | - | 20.00% | - | - | - | - | Upgrade
|
Gross Margin | 100.34% | 91.55% | 98.66% | 95.25% | 97.13% | 97.43% | Upgrade
|
Operating Margin | 24.36% | 29.61% | 39.23% | 35.74% | 27.99% | 19.81% | Upgrade
|
Profit Margin | 16.97% | 23.98% | 26.55% | 16.65% | 8.99% | -5.96% | Upgrade
|
Free Cash Flow Margin | - | 12.89% | 27.50% | 19.28% | 14.65% | -0.74% | Upgrade
|
EBITDA | 3,050 | 4,577 | 6,258 | 4,639 | 2,565 | 1,677 | Upgrade
|
EBITDA Margin | 31.14% | 34.41% | 43.42% | 41.04% | 34.62% | 27.58% | Upgrade
|
D&A For EBITDA | 663.84 | 638.25 | 604.12 | 599.51 | 491.81 | 472.51 | Upgrade
|
EBIT | 2,386 | 3,938 | 5,654 | 4,040 | 2,073 | 1,205 | Upgrade
|
EBIT Margin | 24.36% | 29.61% | 39.23% | 35.74% | 27.98% | 19.81% | Upgrade
|
Effective Tax Rate | 27.46% | 25.33% | 25.23% | 25.02% | 26.37% | - | Upgrade
|
Revenue as Reported | 10,208 | 13,734 | 14,843 | 11,428 | 7,548 | 6,170 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.